Table 1.
The characteristics of infants.
| Category | No (%) 410 (100%) Or Median(range) |
|---|---|
| Age at operation(days) (Median(range)) A (<60 days) B (60–90 days) C (>90 days) |
65(30–135) 90 (22%) 225 (54.9%) 95 (23.2%) |
| Gender Males Females |
186 (45.4%) 224 (54.6%) |
| Weight(KG) (Median(range)) | 4.5(3–7.5) |
| Height(Cm) (Median(range)) | 56(49–66) |
| Type of BA Non-cystic III Cystic III |
390 (95.1%) 20 (4.9%) |
| Associated anomalies BASM Cardiac Others |
13 (3.2%) 7 (1.7%) 9 (2.2%) |
| Onset of jaundice Since birth After birth |
268 (65.4%) 142 (34.6%) |
| Preoperative labs (Median(range)) TB(mg/dL) DB(mg/dL) AST(U/L) ALT(U/L) ALP(U/L) GGT(U/L) Alb(g/dL) INR Platelets (K/uL) |
11.9(4.3–32) 8.5(3–23) 170(51–955) 130(19–4940) 576(131–2175) 828.5(104–3310) 3.6(2.4–4.6) 1(0.8–1.3) 387 (121–1123) |
| Preoperative PHN | 30 (7.3%) |
| Findings in the preoperative US Hepatomegaly Splenomegaly Abnormal gallbladder Hepatic subcapsular flow Positive TC sign |
190 (46.3%) 164 (40%) 336 (82%) 391 (95.4%) 142 (34.6%) |
| Liver portal tracts biopsy findings Ductal and/or ductular proliferation Mild Moderate Marked Fibrosis F0 F1 F2 F3 F4 Presence of macrophages Presence of giant cells Porta hepatis remnant duct size >150 μm <150 μm No ducts |
212 (51.7%) 136 (33.2%) 62 (15.1%) 17 (4.1%) 190 (46.3%) 144 (35.1%) 40 (9.8%) 19 (4.6%) 230 (56.1%) 75 (18.3%) 210 (51.2%) 108 (26.3%) 92 (22.4%) |
| Operative bleeding | 24 (5.9%) |
| Blood transfusion | 6 (1.5%) |
| Plasma transfusion | 23 (5.6%) |
| Operative time(hours) | 4(2.5–7.5) |
| Postoperative hospital stay(days) (Median(range)) | 8(5–70) |
| Postoperative steroid use | 116 (28.3%) |
BA: Biliary atresia, BASM: Biliary atresia splenic malformation, TB: Total bilirubin, DB: Direct bilirubin, AST: Aspartate transaminase, ALT: Alanine transaminase, ALP: Alkaline phosphatase, GGT: Gamma glutamate transferase, Alb: Albumin, INR: International normalization ratio, PHN: Portal hypertension, TC: Triangular cord.